Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene FISH probes

Oxford Gene Technology has launched two CE-IVD labelled fluorescence in situ hybridization (FISH) probes: the Cytocell Aquarius ROS1 Plus Breakapart and RET Breakapart probes. The new probes detect rearrangements in the genome associated with non-small cell lung cancer and expand the company's extensive lung cancer portfolio. They are available in two economical sizes and are both premixed in hybridization buffer.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.